$TVIX It will be interesting to see if Wall Street “learns“ that not all medical updates have significance. Between now and next year everyone and their Mama will report glimmers, tidbits, and pre-results on vaccines and treatment. It’s likely that only a few, or maybe even none will ultimately prove to be significant. Most news now is WAY too early to make any conclusions. For that reason, wise investors ought to consider selling into strength on any ”news”. We already saw this pattern with Remdesivir and may see again if moderna news proves overhyped.